High glucose induces dysfunction and apoptosis in endothelial cells: Is the effect of high glucose persistence more important than concentration?

Experimental and Clinical Endocrinology and Diabetes

Volumn 119, Issue 4, 2011, Pages 225-233

  Zhang, Y ^a   Shi, H ^a   Sun, G ^a   Li, S ^a   Xu, X ^a   Ye, C ^a   Li, X ^a   Wang, S ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

concentration; endothelial cell; high glucose; persistence

Indexed keywords

GLUCOSE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED DEATH DOMAIN PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2;

APOPTOSIS; ARTICLE; CELL FUNCTION; CELL VIABILITY; DIABETES MELLITUS; ENDOTHELIAL DYSFUNCTION; HUMAN; HUMAN CELL; HYPERGLYCEMIA; INFLAMMATION; OXIDATIVE STRESS; PRIORITY JOURNAL; UMBILICAL VEIN ENDOTHELIAL CELL; VASCULAR LESION;

APOPTOSIS; BIOLOGICAL MARKERS; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; GLUCOSE; HUMANS; HYPERGLYCEMIA; INFLAMMATION; OXIDATIVE STRESS; SWEETENING AGENTS;

EID: 79953265632     PISSN: 09477349     EISSN: 14393646     Source Type: Journal    
DOI: 10.1055/s-0030-1255054     Document Type: Article

References (41)

1. Adler AI, Stevens RJ, Neil A et al,. UKPDS 59: Hyperglycemia and Other Potentially Modifiable Risk Factors for Peripheral Vascular Disease in Type 2 Diabetes. Diabetes Care 2002 25 894-899 (Pubitemid 41094289)
2. Bagi Z, Toth E, Koller A et al,. Microvascular dysfunction after transient high glucose is caused by superoxide-dependent reduction in the bioavailability of NO and BH (4). Am J Physiol Heart Circ Physiol 2004 287 2 H626-H633 (Pubitemid 38955293)
3. Blagosklonny MV. Aging: ROS or TOR. Cell Cycle 2008 7 21 3344-3354
4. Brodsky SV, Gao S, Li H et al,. Hyperglycemic switch from mitochondrial nitric oxide to superoxide production in endothelial cells. Am J Physiol Heart Circ Physiol 2002 283 5 H2130-H2139 (Pubitemid 35217047)
5. BrownLee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001 414 813-820 (Pubitemid 34000785)
6. Busik JV, Mohr S, Grant MB. Hyperglycemia-induced reactive oxygen species toxicity to endothelial cells is dependent on paracrine mediators. Diabetes 2008 57 7 1952-1965
7. Cohen G, Riahi Y, Alpert E et al,. The roles of hyperglycaemia and oxidative stress in the rise and collapse of the natural protective mechanism against vascular endothelial cell dysfunction in diabetes. Arch Physiol Biochem 2007 113 4-5 259-267
8. Cooke CL, Davidge ST. Peroxynitrite increases iNOS through NF-kappaB and decreases prostacyclin synthase in endothelial cells. Am J Physiol Cell Physiol 2002 282 2 C395-C402 (Pubitemid 34663199)
9. Esberg LB, Ren J. Role of nitric oxide, tetrahydrobiopterin and peroxynitrite in glucose toxicity-associated contractile dysfunction in ventricular myocytes. Diabetologia 2003 46 10 1419-1427 (Pubitemid 37297213)
10. Gao L, Mann GE. Vascular NAD(P)H oxidase activation in diabetes: a double-edged sword in redox signaling. Cardiovasc Res 2009 82 1 9-20
11. Giugliano D, Ceriello A, Paolisso G. Oxidative stress and diabetic vascular complications. Diabetes Care 1996 19 257-267 (Pubitemid 26070354)
12. Gregg EW, Gu Q, Cheng YJ et al,. Mortality trends in men and women with diabetes, 1971-2000. Ann Intern Med 2007 147 3 149-155 (Pubitemid 351664594)
13. Hanssen KF. Blood glucose control and microvascular and macrovascular complications in diabetes. Diabetes 1997 46 S101-S103 (Pubitemid 27377408)
14. Hayashi T, Matsui-Hirai H, Miyazaki-Akita A et al,. Endothelial cellular senescence is inhibited by nitric oxide: implications in atherosclerosis associated with menopause and diabetes. Proc Natl Acad Sci USA 2006 103 45 17018-17023 (Pubitemid 44737370)
15. Higgins GT, Khan J, Pearce IA. Glycaemic control and control of risk factors in diabetes patients in an ophthalmology clinic: what lessons have we learned from the UKPDS and DCCT studies? Acta Ophthalmol Scand 2007 85 7 772-776 (Pubitemid 47616795)
16. Ho FM, Liu SH, Liau CS et al,. High glucose induced apoptosis in human endothelial cells is mediated by sequential activations of c-Jun NH(2)-terminal kinase and caspase-3. Circulation 2000 101 2618-2624 (Pubitemid 30350641)
17. Hoshiyama M, Li B, Yao J et al,. Effect of high glucose on nitric oxide production and endothelial nitric oxide synthase protein expression in human glomerular endothelial cells. Nephron Exp Nephrol 2003 95 2 e62-e68
18. Hunter I, Nixon GF. Spatial compartmentalization of tumor necrosis factor (TNF) receptor 1-dependent signaling pathways in human airway smooth muscle cells. Lipid rafts are essential for TNF-alpha-mediated activation of RhoA but dispensable for the activation of the NF-kappaB and MAPK pathways. J Biol Chem 2006 281 45 34705-34715 (Pubitemid 46036676)
19. Hur GM, Lewis J, Yang Q et al,. The death domain kinase RIP has an essential role in DNA damage-induced NF-kappa B activation. Genes Dev 2003 17 7 873-882 (Pubitemid 36397375)
20. Inoguchi T, Li P, Umeda F et al,. High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes 2000 49 11 1939-1945
21. Joussen AM, Doehmen S, Le ML et al,. TNF-alpha mediated apoptosis plays an important role in the development of early diabetic retinopathy and long-term histopathological alterations. Mol Vis 2009 15 1418-1428
22. Kern TS. Contributions of inflammatory processes to the development of the early stages of diabetic retinopathy. Exp Diabetes Res 2007 2007 95103
23. Lee CI, Liu X, Zweier JL. Regulation of xanthine oxidative by nitric oxide and peroxynitrite. J Biol Chem 2000 275 9369-9376 (Pubitemid 30185161)
24. Lindström J, Uusitupa M. Lifestyle intervention, diabetes, and cardiovascular disease. Lancet 2008 371 9626 1731-1733 (Pubitemid 351697936)
25. Liu ZG. Molecular mechanism of TNF signaling and beyond. Cell Res 2005 15 1 24-27
26. Lundberg JO, Weitzberg E. NO generation from nitrite and its role in vascular control. Arteriosclerosis, Thrombosis, and Vascular Biology 2005 25 5 915-922 (Pubitemid 40627834)
27. Madamanchi NR, Runge MS. Mitochondrial dysfunction in atherosclerosis. Circ Res 2007 100 4 460-473 (Pubitemid 46673256)
28. Nakagami H, Kaneda Y, Ogihara T et al,. Endothelial dysfunction in hyperglycemia as a trigger of atherosclerosis. Curr Diabetes Rev 2005 1 1 59-63
29. Newsholme P, Haber EP, Hirabara SM et al,. Diabetes associated cell stress and dysfunction: role of mitochondrial and non-mitochondrial ROS production and activity. J Physiol 2007 Aug 15 583 Pt 1 9-24 (Pubitemid 47244241)
30. Okuda Y, Kawashima K, Suzuki S et al,. Restoration of nitric oxide production by aldose reductase inhibitor in human endothelial cells cultured in high-glucose medium. Life Sci 1997 60 3 PL53-PL56
31. Oliveira HC, Cosso RG, Alberici LC et al,. Oxidative stress in atherosclerosis-prone mouse is due to low antioxidant capacity of mitochondria. FASEB J 2005 19 2 278-280 (Pubitemid 40189281)
32. Pacher P, Beckman JS, Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev 2007 87 1 315-424 (Pubitemid 46217686)
33. Piconi L, Corgnali M, Da Ros R et al,. The protective effect of rosuvastatin in human umbilical endothelial cells exposed to constant or intermittent high glucose. J Diabetes Complications 2008 22 1 38-45
34. Quagliaro L, Piconi L, Assaloni R et al,. Intermittent high glucose enhances ICAM-1, VCAM-1 and E-selectin expression in human umbilical vein endothelial cells in culture: the distinct role of protein kinase C and mitochondrial superoxide production. Atherosclerosis 2005 183 2 259-267 (Pubitemid 41579276)
35. Rajesh M, Mukhopadhyay P, Bátkai S et al,. Cannabidiol attenuates high glucose-induced endothelial cell inflammatory response and barrier disruption. Am J Physiol Heart Circ Physiol 2007 293 1 H610-H619 (Pubitemid 47105122)
36. Raskin P, Rosenstock J. Blood glucose control and diabetic complications. Ann Intern Med 1986 105 2 254-263 (Pubitemid 16039305)
37. Sheikh MS, Huang Y. Death receptor activation complexes: it takes 2 to activate TNF receptor 1. Cell Cycle 2003 2 6 550-552
38. Srinivasan S, Hatley ME, Bolick DT et al,. Hyperglycaemia-induced superoxide production decreases eNOS expression via AP-1 activation in aortic endothelial cells. Diabetologia 2004 47 10 1727-1734 (Pubitemid 40022408)
39. Xiao-Yun X, Zhuo-Xiong C, Min-Xiang L et al,. Ceramide mediates inhibition of the AKT/eNOS signaling pathway by palmitate in human vascular endothelial cells. Med Sci Monit 2009 15 9 BR254-BR261
40. Xu HQ, Hao HP, Zhang X et al,. Morroniside protects cultured human umbilical vein endothelial cells from damage by high ambient glucose. Acta Pharmacol Sin 2004 25 4 412-415 (Pubitemid 38470407)
41. Yang Z, Mo X, Gong Q et al,. Critical effect of VEGF in the process of endothelial cell apoptosis induced by high glucose. Apoptosis 2008 13 11 1331-1343